Use of cytokines and mitogens to inhibit pathological immune responses
US6797267B2 · kind B2 · utility
9Cited by
4References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 21, 2001 |
| Grant date | Sep 28, 2004 |
| Priority date | — |
| Expiry date | Apr 10, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/599
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is generally related to methods of treating autoimmune diseases, including both antibody-mediated and cell-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.